DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Rozeman EA, Prevoo W, Meier MAJ. et al.
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM).
Melanoma Res 2020;
30 (03) 252-260
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.